The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders.
about
A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric ResearchUtilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neuronsPsychosis Risk Candidate ZNF804A Localizes to Synapses and Regulates Neurite Formation and Dendritic Spine StructureNon-coding RNAs in pluripotency and neural differentiation of human pluripotent stem cells.The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders.Bio-collections in autism research.Future directions for research in autism spectrum disorders.Scalable topographies to support proliferation and Oct4 expression by human induced pluripotent stem cells.Defining Precision Medicine Approaches to Autism Spectrum Disorders: Concepts and ChallengesThe potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy.Mouse models and induced pluripotent stem cells in researching psychiatric disorders.Human induced pluripotent stem cells as a research tool in Alzheimer's disease.Modelling Autistic Neurons with Induced Pluripotent Stem Cells.Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder.Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?Stem cell-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic abnormalities during early development.Understanding role of steroids in typical and atypical brain development: Advantages of using a "brain in a dish" approach.Autism spectrum disorders--an emerging area in psychopharmacology.
P2860
Q26770097-A02546B7-2F57-460B-9EB5-9CBEFCC19E69Q28081565-817F2C50-BF75-4D22-AF02-60A865B156F0Q33288801-C57F06CB-B981-42B2-A2E8-1AED717D1516Q33647019-72DAC523-4C34-4057-86F5-6A10CEA7BDFEQ33827324-BD5BDC2B-D530-4483-8B32-E81325C4AFAAQ33892169-9A56FAEA-776E-4A17-988C-47839A6E1975Q34180429-CA851E4E-E416-462A-8BF5-05F9FCBBE8EEQ35891769-CBC99764-D778-42EC-A755-07585F819C9EQ37447215-EA7D10FE-17CC-43F9-B68B-E4EDF88A70ABQ38349063-1717DCE4-5735-438C-94A9-7DB8B954AE81Q38641366-48D0BB3A-7B5E-4F38-9AF5-953A7C54535FQ38643034-1C91C99A-5C9E-43C0-94CE-2161EA546AC3Q39334479-D611A4B1-4645-4B91-99B0-A84C9FC822D8Q40128301-C1E111E9-7E45-496E-B3C8-9CA03B08B641Q45871232-99D20268-AAC5-4293-8D3B-66DB0ED3D2A9Q46032507-C46C5C6E-CC1F-44E9-81FC-F3A98BFE6E83Q48022573-8848AD34-0FC7-4B92-8849-338606BC3968Q50343855-65A9E148-3182-461C-ABD7-CC4806A2E033
P2860
The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The utility of patient specifi ...... f Autistic Spectrum Disorders.
@en
The utility of patient specifi ...... f Autistic Spectrum Disorders.
@nl
type
label
The utility of patient specifi ...... f Autistic Spectrum Disorders.
@en
The utility of patient specifi ...... f Autistic Spectrum Disorders.
@nl
prefLabel
The utility of patient specifi ...... f Autistic Spectrum Disorders.
@en
The utility of patient specifi ...... f Autistic Spectrum Disorders.
@nl
P2093
P2860
P921
P1433
P1476
The utility of patient specifi ...... f Autistic Spectrum Disorders.
@en
P2093
Aaron R Jeffries
Annie Kathuria
Caroline Ogilvie
Dafe Uwanogho
Graham Cocks
Rosemary Dixon
Sarah Curran
Thomas Steckler
Victoria Wood
Walter Lucchesi
P2860
P2888
P304
P356
10.1007/S00213-013-3196-4
P577
2013-07-10T00:00:00Z
2014-03-01T00:00:00Z